A Phase 1 Study of Avapritinib in Combination With Decitabine in Patients With Systemic Mastocytosis With an Associated Hematologic Neoplasm (SM-AHN)
Latest Information Update: 17 Dec 2024
At a glance
- Drugs Avapritinib (Primary) ; Cedazuridine/decitabine (Primary) ; Decitabine (Primary)
- Indications Systemic mastocytosis
- Focus Adverse reactions
Most Recent Events
- 28 Mar 2024 New trial record